Summary of characteristics of patients in the UK Biobank dataset
| Train | Validate | Test | |
| Number of patients | 31 403 | 10 420 | 10 474 |
| Number of images | 61 554 | 20 392 | 20 503 |
| Age, years | 56.9 (8.2) | 56.7 (8.2) | 56.6 (8.2) |
| Gender (%, male) | 46.3% | 46.1% | 46.2% |
| Body mass index, kg/m2 | 27.4 (4.7) | 27.3 (4.8) | 27.4 (4.8) |
| Systolic blood pressure, mm Hg | 139.9 (19.7) | 139.8 (19.7) | 139.7 (19.4) |
| Diastolic blood pressure, mm Hg | 81.9 (10.7) | 81.9 (10.7) | 81.8 (10.6) |
| Haemoglobin A1c, mmol/mol | 36.1 (6.6) | 36.3 (6.9) | 36.2 (7.2) |
| High-density lipoprotein cholesterol, mmol/L | 1.48 (0.39) | 1.48 (0.39) | 1.48 (0.39) |
| Low-density lipoprotein cholesterol, mmol/L | 3.53 (0.86) | 3.52 (0.86) | 3.53 (0.86) |
| Triglycerides, mmol/L | 1.68 (0.96) | 1.67 (0.96) | 1.68 (0.97) |
| Current smoker (%) | 2971 (9.46%) | 1030 (9.89%) | 1067 (10.19%) |
| Number of diabetes (%) | 1743 (5.55%) | 603 (5.79%) | 596 (5.69%) |
| Number of MACE in 5 years (%) | 327 (1.04%) | 119 (1.14%) | 132 (1.26%) |
| SCORE (5 years) %; median (IQR) | 0.590 (0.187–1.31) | 0.57 (0.180–1.30) | 0.57 (0.183–1.25) |
| SCORE (10 years) %; median (IQR) | 1.62 (0.557–3.43) | 1.57 (0.536–3.39) | 1.65 (0.544–3.29) |
| SCORE 2 (10 years) %; median (IQR) | 3.92 (2.21–6.03) | 3.93 (2.22–6.19) | 3.92 (2.23–6.07) |
| Pooled Cohort Equation (10 years) %; median (IQR) | 3.56 (1.62–7.16) | 3.56 (1.60–7.52) | 3.59 (1.64–7.27) |
| Framingham Risk Score (10 years) %; median (IQR) | 11.29 (6.43–18.36) | 11.32 (6.42–19.05) | 11.35 (6.50–18.81) |
Values are presented as mean (SD) or median (IQR).
MACE, major adverse cardiovascular events; SCORE, Systematic COronary Risk Evaluation.